Oncosil Medical Equity 2024

Oncosil Medical Aktienanalyse

What does Oncosil Medical do?

Oncosil Medical Ltd is an Australian company specializing in the development and distribution of innovative medical products for the treatment of cancer. The company was founded in 2005 and is based in Sydney. The business model of Oncosil Medical is based on research, development, and marketing of products specifically tailored to the needs of cancer patients. The company focuses on developing medical products that aim to improve the effectiveness of radiation therapy and chemotherapy. The core product of Oncosil Medical is the Oncosil implant. It is a small, implantable catheter containing tiny radioactive silicon particles. The implant is directly inserted into the tumor and releases controlled radiation to specifically destroy the tumor. The Oncosil implant is a promising and innovative new treatment option for many cancer patients. It is particularly suitable for patients with locally advanced pancreatic cancer, which is especially difficult to treat. Studies have shown that the Oncosil implant can significantly improve patients' survival rate. Oncosil Medical also provides other products, such as the Microsil transponder. The Microsil transponder is a small implant used in radiation therapy to make the irradiation of the tumor more effective. The transponder is directly inserted into the tumor, allowing medical professionals to precisely target the radiation to the tumor. In addition to developing and marketing innovative medical products, Oncosil Medical also has a research and development department. The company is constantly searching for new cancer treatment methods and works closely with scientists and researchers to develop new technologies. Oncosil Medical operates in several areas. In addition to developing and marketing medical products, the company also offers a training and education program for doctors and medical personnel. The program ensures that all users of Oncosil Medical's products have the necessary skills and knowledge to use the products safely and effectively. The company also has its own regulatory affairs department, which deals with the application for approvals for new products and procedures. This department works closely with authorities and regulatory agencies to ensure that all products from Oncosil Medical comply with applicable regulations and standards. Overall, Oncosil Medical is an innovative and emerging company specializing in the development and marketing of medical products for cancer treatment. With its highly skilled team of scientists, doctors, and qualified professionals, the company stays up to date with the latest research and technology to ensure that its products are always state-of-the-art and provide customers with the best possible treatment option. Oncosil Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Oncosil Medical's Equity

Oncosil Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Oncosil Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Oncosil Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Oncosil Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Oncosil Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Oncosil Medical stock

What is the equity of Oncosil Medical this year?

Oncosil Medical has equity of 9.88 M AUD this year.

What was the equity of Oncosil Medical compared to the previous year?

The equity of Oncosil Medical has increased/decreased by -11.49% decreased compared to the previous year.

What impact does a high equity have on investors of Oncosil Medical?

A high equity is advantageous for investors of Oncosil Medical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Oncosil Medical?

A low equity can be a risk for investors of Oncosil Medical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Oncosil Medical affect the company?

An increase in equity of Oncosil Medical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Oncosil Medical affect the company?

A reduction in equity of Oncosil Medical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Oncosil Medical?

Some factors that can affect the equity of Oncosil Medical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Oncosil Medical so important for investors?

The equity of Oncosil Medical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Oncosil Medical take to change the equity?

To change equity, Oncosil Medical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Oncosil Medical pay?

Over the past 12 months, Oncosil Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncosil Medical is expected to pay a dividend of 0 AUD.

What is the dividend yield of Oncosil Medical?

The current dividend yield of Oncosil Medical is .

When does Oncosil Medical pay dividends?

Oncosil Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncosil Medical?

Oncosil Medical paid dividends every year for the past 0 years.

What is the dividend of Oncosil Medical?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncosil Medical located?

Oncosil Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncosil Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncosil Medical from 9/13/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Oncosil Medical pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Oncosil Medical in the year 2023?

In the year 2023, Oncosil Medical distributed 0 AUD as dividends.

In which currency does Oncosil Medical pay out the dividend?

The dividends of Oncosil Medical are distributed in AUD.